Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania2Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania.
JAMA Pediatr. 2014 Dec;168(12):1107-13. doi: 10.1001/jamapediatrics.2014.1609.
Cough is one of the most common reasons why children visit a health care professional.
To compare the effect of a novel formulation of pasteurized agave nectar vs placebo and no treatment on nocturnal cough and the sleep difficulty associated with nonspecific acute cough in infants and toddlers.
DESIGN, SETTING, AND PARTICIPANTS: In this randomized clinical trial performed in 2 university-affiliated outpatient, general pediatric practices from January 28, 2013, through February 28, 2014, children 2 to 47 months old with nonspecific acute cough duration of 7 days or less were studied. Surveys were administered to parents on 2 consecutive days, the day of presentation (when no medication had been given the prior evening) and the next day (when agave nectar, placebo, or no treatment had been administered to their child before bedtime) according to a partially double-blind randomization scheme.
A single dose of agave nectar, placebo, or no treatment administered 30 minutes before bedtime.
Cough frequency, cough severity, cough bothersomeness, congestion severity, rhinorrhea severity, and cough effect on child and parent sleep.
Significant differences in symptom improvement were detected between the study groups (P < .05 for all, except P = .06 for cough bothersomeness), with agave nectar and placebo proving to be superior to no treatment, but no significant differences for any outcome were found when comparing agave nectar against placebo.
In a comparison of agave nectar, placebo, and no treatment, a placebo effect was demonstrated, with no additional benefit offered by agave nectar. Health care professionals should consider the potential benefits and costs when recommending a treatment with only a placebo effect for infants and toddlers with nonspecific acute cough.
clinicaltrials.gov Identifier: NCT01721395.
咳嗽是儿童就诊的最常见原因之一。
比较新型巴氏处理龙舌兰花蜜制剂与安慰剂和无治疗在婴幼儿非特异性急性咳嗽夜间咳嗽和相关睡眠困难的效果。
设计、地点和参与者:这是一项在 2013 年 1 月 28 日至 2014 年 2 月 28 日期间在 2 家大学附属的普通儿科门诊进行的随机临床试验,研究对象为病程 7 天以内的 2 至 47 个月龄非特异性急性咳嗽儿童。按照部分双盲随机分组方案,在连续 2 天对父母进行问卷调查,分别为就诊日(前一晚未给药时)和次日(睡前给予龙舌兰花蜜、安慰剂或无治疗时)。
睡前 30 分钟给予单剂量龙舌兰花蜜、安慰剂或无治疗。
咳嗽频率、咳嗽严重程度、咳嗽困扰、鼻塞严重程度、流涕严重程度以及咳嗽对儿童和父母睡眠的影响。
在症状改善方面,各组间存在显著差异(除咳嗽困扰外,所有比较 P 值均<.05,P 值为.06),龙舌兰花蜜和安慰剂均优于无治疗,但龙舌兰花蜜与安慰剂比较时,任何结果均无显著差异。
在龙舌兰花蜜、安慰剂和无治疗的比较中,安慰剂效应显著,龙舌兰花蜜没有提供额外的益处。对于非特异性急性咳嗽的婴幼儿,当推荐一种仅有安慰剂效应的治疗方法时,医疗保健专业人员应考虑潜在的获益和成本。
clinicaltrials.gov 标识符:NCT01721395。